Work

Supplementary Figure 1 from Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 112K

DOI: 10.1158/1078-0432.22443294

Authors: Steven I. Park, Jaideep Shenoi, Shani M. Frayo, Donald K. Hamlin, Yukang Lin, D. Scott Wilbur, Patrick S. Stayton, Nural Orgun, Mark Hylarides, Franz Buchegger, Aimee L. Kenoyer, Amanda Axtman, Ajay K. Gopal, Damian J. Green, John M. Pagel, Oliver W. Press

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361819156

Cites:

Cited by:

Related to: 10